» Articles » PMID: 35944840

Unique Mutations in SARS-CoV-2 Omicron Subvariants' Non-spike Proteins: Potential Impacts on Viral Pathogenesis and Host Immune Evasion

Overview
Journal Microb Pathog
Date 2022 Aug 9
PMID 35944840
Authors
Affiliations
Soon will be listed here.
Abstract

SARS-CoV-2 is the causative agent behind the ongoing COVID-19 pandemic. This virus is a cumulative outcome of mutations, leading to frequent emergence of new variants and their subvariants. Some of them are a matter of high concern, while others are variants of interest for studying the mutational effect. The major five variants of concern (VOCs) are Alpha (B.1.1.7), Beta (B.1.315), Gamma (P.1), Delta (B.1.617.2), and Omicron (B.1.1.529.*/BA.*). Omicron itself has >100 subvariants at present, among which BA.1 (21K), BA.2 (21L), BA.4 (22A), BA.5 (22B), and BA.2.12.1 (22C) are the dominant ones. Undoubtedly, these variants and sometimes their progeny subvariants have significant differences in their spike region that impart them the unique properties they harbor. But alongside, the mutations in their non-spike regions could also be responsible elements behind their characteristics, such as replication time, virulence, survival, host immune evasion, and such. There exists a probability that these mutations of non-spike proteins may also impart epistatic effects that are yet to be brought to light. The focus of this review encompasses the non-spike mutations of Omicron, especially in its widely circulating subvariants (BA.1, BA.2, BA.4, BA.5, and BA.2.12.1). The mutations such as in NSP3, NSP6, NSP13, M protein, ORF7b, and ORF9b are mentioned few of all, which might have led to the varying properties, including growth advantages, higher transmission rate, lower infectivity, and most importantly better host immune evasion through natural killer cell inactivation, autophagosome-lysosome fusion prevention, host protein synthesis disruption, and so on. This aspect of Omicron subvariants has not yet been explored. Further study of alteration of expression or interaction profile of these non-spike mutations bearing proteins, if present, can add a great deal of knowledge to the current understanding of the viral properties and thus effective prevention strategies.

Citing Articles

Betacoronavirus internal protein: role in immune evasion and viral pathogenesis.

Gunawardene C, Wong L J Virol. 2025; 99(2):e0135324.

PMID: 39760492 PMC: 11852921. DOI: 10.1128/jvi.01353-24.


iHDSel software: The price equation and the population stability index to detect genomic patterns compatible with selective sweeps. An example with SARS-CoV-2.

Carvajal-Rodriguez A Biol Methods Protoc. 2024; 9(1):bpae089.

PMID: 39679303 PMC: 11646571. DOI: 10.1093/biomethods/bpae089.


SARS-CoV-2 Nsp6-Omicron causes less damage to the Drosophila heart and mouse cardiomyocytes than ancestral Nsp6.

Zhu J, Lee J, Wang G, Duan J, van de Leemput J, Lee H Commun Biol. 2024; 7(1):1609.

PMID: 39627475 PMC: 11615247. DOI: 10.1038/s42003-024-07307-x.


Complete genome sequencing of SARS-CoV-2 strains that were circulating in Uzbekistan over the course of four pandemic waves.

Esonova G, Abdurakhimov A, Ibragimova S, Kurmaeva D, Gulomov J, Mirazimov D PLoS One. 2024; 19(11):e0298940.

PMID: 39561193 PMC: 11575833. DOI: 10.1371/journal.pone.0298940.


Enhanced predictability and interpretability of COVID-19 severity based on SARS-CoV-2 genomic diversity: a comprehensive study encompassing four years of data.

Miao M, Ma Y, Tan J, Chen R, Men K Sci Rep. 2024; 14(1):26992.

PMID: 39506014 PMC: 11541897. DOI: 10.1038/s41598-024-78493-1.


References
1.
Gadlage M, Sparks J, Beachboard D, Cox R, Doyle J, Stobart C . Murine hepatitis virus nonstructural protein 4 regulates virus-induced membrane modifications and replication complex function. J Virol. 2009; 84(1):280-90. PMC: 2798404. DOI: 10.1128/JVI.01772-09. View

2.
Ou J, Lan W, Wu X, Zhao T, Duan B, Yang P . Tracking SARS-CoV-2 Omicron diverse spike gene mutations identifies multiple inter-variant recombination events. Signal Transduct Target Ther. 2022; 7(1):138. PMC: 9039610. DOI: 10.1038/s41392-022-00992-2. View

3.
Harcourt B, Jukneliene D, Kanjanahaluethai A, Bechill J, Severson K, Smith C . Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity. J Virol. 2004; 78(24):13600-12. PMC: 533933. DOI: 10.1128/JVI.78.24.13600-13612.2004. View

4.
Hagemeijer M, Ulasli M, Vonk A, Reggiori F, Rottier P, de Haan C . Mobility and interactions of coronavirus nonstructural protein 4. J Virol. 2011; 85(9):4572-7. PMC: 3126240. DOI: 10.1128/JVI.00042-11. View

5.
Arya R, Kumari S, Pandey B, Mistry H, Bihani S, Das A . Structural insights into SARS-CoV-2 proteins. J Mol Biol. 2020; 433(2):166725. PMC: 7685130. DOI: 10.1016/j.jmb.2020.11.024. View